According to the Zhitong Finance App, Kunbo Medical-B (02216) announced interim results for the six months ended June 30, 2026. The group obtained revenue of US$3.288 million, an increase of 99% over the previous year; adjusted net loss of US$7.982 million, an increase of 14.7% over the previous year; and a loss of 0.02 US dollars per share.

According to the announcement, revenue growth came from the Chinese market, and the region achieved year-on-year growth in equipment and consumables.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.